HK Stock MarketDetailed Quotes

01652 FUSEN PHARM

Watchlist

0.810
0.0000.00%

Market Closed Dec 27 16:08 CST

598.83MMarket Cap-6.09P/E (TTM)

FUSEN PHARM Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

(Q6)Jun 30, 2020

(FY)Dec 31, 2019

Turnover

-41.65%196.32M

15.02%565.61M

103.15%336.44M

27.51%491.76M

-22.69%165.61M

-20.78%385.66M

-13.45%214.21M

19.51%486.85M

26.00%247.5M

-11.83%407.39M

Operating income

-41.65%196.32M

15.02%565.61M

103.15%336.44M

27.51%491.76M

-22.69%165.61M

-20.78%385.66M

-13.45%214.21M

19.51%486.85M

26.00%247.5M

-11.83%407.39M

Cost of sales

42.51%-90.45M

0.24%-266.1M

-83.19%-157.32M

-52.83%-266.74M

10.53%-85.88M

20.95%-174.53M

16.30%-95.98M

-13.28%-220.79M

-27.96%-114.67M

7.52%-194.9M

Operating expenses

42.51%-90.45M

0.24%-266.1M

-83.19%-157.32M

-52.83%-266.74M

10.53%-85.88M

20.95%-174.53M

16.30%-95.98M

-13.28%-220.79M

-27.96%-114.67M

7.52%-194.9M

Gross profit

-40.89%105.87M

33.10%299.51M

124.65%179.12M

6.58%225.02M

-32.56%79.73M

-20.65%211.13M

-10.99%118.23M

25.22%266.07M

24.35%132.83M

-15.45%212.49M

Selling expenses

33.98%-52.22M

-17.54%-139.54M

-77.36%-79.09M

-30.54%-118.72M

12.41%-44.59M

15.33%-90.95M

9.76%-50.91M

4.79%-107.41M

0.83%-56.42M

-25.92%-112.81M

Administrative expenses

-1.28%-36.21M

-36.81%-74.9M

-28.14%-35.76M

16.08%-54.75M

11.50%-27.9M

17.29%-65.24M

33.98%-31.53M

-34.30%-78.87M

-84.29%-47.76M

-19.12%-58.73M

Research and development expenses

-137.47%-57.06M

-329.61%-65.2M

---24.03M

---15.18M

----

Impairment and provision

----

---22.64M

----

-Goodwill impairment

----

---22.64M

----

Special items of operating profit

313.44%3.08M

-98.02%146K

-2,431.58%-1.44M

362.13%7.38M

-100.52%-57K

-159.46%-2.82M

119.95%11.06M

-81.21%4.73M

-40.77%5.03M

6.57%25.19M

Operating profit

-194.17%-36.54M

-54.26%20.02M

440.55%38.8M

-16.07%43.76M

-84.68%7.18M

-15.75%52.14M

39.10%46.85M

-6.45%61.88M

3.62%33.68M

-51.39%66.15M

Financing income

-97.47%19K

-78.50%424K

-21.09%752K

-22.91%1.97M

-21.37%953K

79.01%2.56M

51.69%1.21M

-60.99%1.43M

-9.62%799K

9.47%3.66M

Financing cost

-146.41%-7.38M

47.64%-9.27M

72.50%-2.99M

-83.29%-17.7M

-53.86%-10.88M

-5.42%-9.66M

-46.37%-7.07M

13.04%-9.16M

16.87%-4.83M

32.48%-10.53M

Share of profits of associates

-24.45%-1.07M

1.05%-9.11M

72.27%-859K

32.52%-9.2M

-62.20%-3.1M

---13.64M

---1.91M

----

Share of profit from joint venture company

97.18%-361K

5.33%-11.19M

-775.85%-12.81M

-201.26%-11.82M

-112.47%-1.46M

-51.88%11.67M

-4.17%11.72M

434.77%24.25M

--12.23M

--4.54M

Special items of earning before tax

----

46.51%-20.33M

----

-97.13%-38.01M

----

---19.28M

----

Earning before tax

-297.96%-45.33M

4.98%-29.45M

413.09%22.9M

-230.27%-30.99M

-114.40%-7.31M

-69.66%23.79M

21.30%50.8M

22.86%78.41M

51.87%41.88M

-48.46%63.81M

Tax

229.88%8.38M

-87.03%-6.85M

-2,832.63%-6.45M

49.00%-3.66M

103.38%236K

54.39%-7.18M

17.27%-6.99M

-36.19%-15.74M

-119.86%-8.45M

47.25%-11.56M

After-tax profit from continuing operations

-324.65%-36.95M

-4.74%-36.3M

332.40%16.45M

-308.60%-34.65M

-116.15%-7.08M

-73.49%16.61M

31.05%43.81M

19.92%62.67M

40.86%33.43M

-48.72%52.26M

Earning after tax

-324.65%-36.95M

-4.74%-36.3M

332.40%16.45M

-308.60%-34.65M

-116.15%-7.08M

-73.49%16.61M

31.05%43.81M

19.92%62.67M

40.86%33.43M

-48.72%52.26M

Minority profit

11.11%-8K

63.27%-18K

77.50%-9K

-53.13%-49K

63.64%-40K

99.57%-32K

92.69%-110K

-535.15%-7.46M

-2,053.25%-1.5M

-4,451.85%-1.18M

Profit attributable to shareholders

-324.48%-36.94M

-4.83%-36.28M

333.85%16.46M

-307.90%-34.61M

-116.02%-7.04M

-76.27%16.65M

25.72%43.92M

31.25%70.13M

47.68%34.93M

-47.55%53.43M

Basic earnings per share

-350.00%-0.05

0.00%-0.05

300.00%0.02

-350.00%-0.05

-116.67%-0.01

-77.78%0.02

50.00%0.06

28.57%0.09

33.33%0.04

-53.33%0.07

Diluted earnings per share

-350.00%-0.05

0.00%-0.05

300.00%0.02

-350.00%-0.05

-116.67%-0.01

-77.78%0.02

50.00%0.06

28.57%0.09

33.33%0.04

-53.33%0.07

Currency Unit

CNY

Accounting Standards

IAS

Audit Opinions

Unqualified Opinion

Auditor

KPMG

	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020	(Q6)Jun 30, 2020	(FY)Dec 31, 2019
Turnover	-41.65%196.32M	15.02%565.61M	103.15%336.44M	27.51%491.76M	-22.69%165.61M	-20.78%385.66M	-13.45%214.21M	19.51%486.85M	26.00%247.5M	-11.83%407.39M
Operating income	-41.65%196.32M	15.02%565.61M	103.15%336.44M	27.51%491.76M	-22.69%165.61M	-20.78%385.66M	-13.45%214.21M	19.51%486.85M	26.00%247.5M	-11.83%407.39M
Cost of sales	42.51%-90.45M	0.24%-266.1M	-83.19%-157.32M	-52.83%-266.74M	10.53%-85.88M	20.95%-174.53M	16.30%-95.98M	-13.28%-220.79M	-27.96%-114.67M	7.52%-194.9M
Operating expenses	42.51%-90.45M	0.24%-266.1M	-83.19%-157.32M	-52.83%-266.74M	10.53%-85.88M	20.95%-174.53M	16.30%-95.98M	-13.28%-220.79M	-27.96%-114.67M	7.52%-194.9M
Gross profit	-40.89%105.87M	33.10%299.51M	124.65%179.12M	6.58%225.02M	-32.56%79.73M	-20.65%211.13M	-10.99%118.23M	25.22%266.07M	24.35%132.83M	-15.45%212.49M
Selling expenses	33.98%-52.22M	-17.54%-139.54M	-77.36%-79.09M	-30.54%-118.72M	12.41%-44.59M	15.33%-90.95M	9.76%-50.91M	4.79%-107.41M	0.83%-56.42M	-25.92%-112.81M
Administrative expenses	-1.28%-36.21M	-36.81%-74.9M	-28.14%-35.76M	16.08%-54.75M	11.50%-27.9M	17.29%-65.24M	33.98%-31.53M	-34.30%-78.87M	-84.29%-47.76M	-19.12%-58.73M
Research and development expenses	-137.47%-57.06M	-329.61%-65.2M	---24.03M	---15.18M	----	----	----	----	----	----
Impairment and provision	----	----	----	----	----	----	----	---22.64M	----	----
-Goodwill impairment	----	----	----	----	----	----	----	---22.64M	----	----
Special items of operating profit	313.44%3.08M	-98.02%146K	-2,431.58%-1.44M	362.13%7.38M	-100.52%-57K	-159.46%-2.82M	119.95%11.06M	-81.21%4.73M	-40.77%5.03M	6.57%25.19M
Operating profit	-194.17%-36.54M	-54.26%20.02M	440.55%38.8M	-16.07%43.76M	-84.68%7.18M	-15.75%52.14M	39.10%46.85M	-6.45%61.88M	3.62%33.68M	-51.39%66.15M
Financing income	-97.47%19K	-78.50%424K	-21.09%752K	-22.91%1.97M	-21.37%953K	79.01%2.56M	51.69%1.21M	-60.99%1.43M	-9.62%799K	9.47%3.66M
Financing cost	-146.41%-7.38M	47.64%-9.27M	72.50%-2.99M	-83.29%-17.7M	-53.86%-10.88M	-5.42%-9.66M	-46.37%-7.07M	13.04%-9.16M	16.87%-4.83M	32.48%-10.53M
Share of profits of associates	-24.45%-1.07M	1.05%-9.11M	72.27%-859K	32.52%-9.2M	-62.20%-3.1M	---13.64M	---1.91M	----	----	----
Share of profit from joint venture company	97.18%-361K	5.33%-11.19M	-775.85%-12.81M	-201.26%-11.82M	-112.47%-1.46M	-51.88%11.67M	-4.17%11.72M	434.77%24.25M	--12.23M	--4.54M
Special items of earning before tax	----	46.51%-20.33M	----	-97.13%-38.01M	----	---19.28M	----	----	----	----
Earning before tax	-297.96%-45.33M	4.98%-29.45M	413.09%22.9M	-230.27%-30.99M	-114.40%-7.31M	-69.66%23.79M	21.30%50.8M	22.86%78.41M	51.87%41.88M	-48.46%63.81M
Tax	229.88%8.38M	-87.03%-6.85M	-2,832.63%-6.45M	49.00%-3.66M	103.38%236K	54.39%-7.18M	17.27%-6.99M	-36.19%-15.74M	-119.86%-8.45M	47.25%-11.56M
After-tax profit from continuing operations	-324.65%-36.95M	-4.74%-36.3M	332.40%16.45M	-308.60%-34.65M	-116.15%-7.08M	-73.49%16.61M	31.05%43.81M	19.92%62.67M	40.86%33.43M	-48.72%52.26M
Earning after tax	-324.65%-36.95M	-4.74%-36.3M	332.40%16.45M	-308.60%-34.65M	-116.15%-7.08M	-73.49%16.61M	31.05%43.81M	19.92%62.67M	40.86%33.43M	-48.72%52.26M
Minority profit	11.11%-8K	63.27%-18K	77.50%-9K	-53.13%-49K	63.64%-40K	99.57%-32K	92.69%-110K	-535.15%-7.46M	-2,053.25%-1.5M	-4,451.85%-1.18M
Profit attributable to shareholders	-324.48%-36.94M	-4.83%-36.28M	333.85%16.46M	-307.90%-34.61M	-116.02%-7.04M	-76.27%16.65M	25.72%43.92M	31.25%70.13M	47.68%34.93M	-47.55%53.43M
Basic earnings per share	-350.00%-0.05	0.00%-0.05	300.00%0.02	-350.00%-0.05	-116.67%-0.01	-77.78%0.02	50.00%0.06	28.57%0.09	33.33%0.04	-53.33%0.07
Diluted earnings per share	-350.00%-0.05	0.00%-0.05	300.00%0.02	-350.00%-0.05	-116.67%-0.01	-77.78%0.02	50.00%0.06	28.57%0.09	33.33%0.04	-53.33%0.07
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS	IAS
Audit Opinions	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion
Auditor	--	KPMG	--	KPMG	--	KPMG	--	KPMG	--	KPMG

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Trending HK Stocks